The expression of CHAF1A was positively correlated with the tumor size and clinical stage of glioblastoma, and negatively correlated with the overall survival rate, which could be used as an independent biological marker to estimate the prognosis [10]. The gene discussed is CHAF1A; the disease is neoplasm.